Article
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.
Endocrine-related cancer - 1 Aug 2015
Ríos Rafael, Lupiañez Carmen Belén, Campa Daniele, Martino Alessandro, Martínez-López Joaquin, Martínez-Bueno Manuel, Varkonyi Judit, García-Sanz Ramón, Jamroziak Krzysztof, Dumontet Charles, Cayuela Andrés Jerez, Wętek Marzena, Landi Stephano, Rossi Anna Maria, Lesueur Fabienne, Reis Rui Manuel, Moreno Victor, Marques Herlander, Jurczyszyn Artur, Andersen Vibeke, Vogel Ulla, Buda Gabriele, Orciuolo Enrico, Jacobsen Svend E H, Petrini Mario, Vangsted Annette J, Gemignani Federica, Canzian Federico, Jurado Manuel, Sainz Juan
Abstract excerpt
Type 2 diabetes (T2D) has been suggested to be a risk factor for multiple myeloma (MM), but the relationship between the two traits is still not well understood. The aims of this study were to evaluate whether 58 genome-wide-association-studies (GWAS)-identified common variants for T2D influence the risk of developing MM and to determine whether predictive models built with these variants might help to predict...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.